Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study Comparing Epcoritamab and Lenalidomide with a Drug Combination for Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Not recruiting
Investigated Diseases:Investigated Drugs:
+5
Study on the Safety and Effects of Tolinapant in Patients with Advanced Solid Tumors and Lymphomas
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Copanlisib with Rituximab and CHOP for Untreated Diffuse Large B-Cell Lymphoma in Patients Aged 18-80
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on MB-CART19.1 for Patients with Relapsed or Refractory CD19 Positive B Cell Malignancies
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on the Effectiveness and Safety of Polatuzumab Vedotin, Rituximab, and CHP in Patients with Untreated Diffuse Large B-Cell Lymphoma
Not recruiting
Investigated Diseases:Investigated Drugs:
+2
Study of Brentuximab Vedotin Combined with R-DHAP Chemotherapy for Patients with Relapsed or Treatment-Resistant CD30-Positive Diffuse Large B-Cell Lymphoma Who Are Eligible for Stem Cell Transplant
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on Prednisone and Vitamin D for Elderly Patients with Diffuse Large B-Cell Lymphoma
Not recruiting
Investigated Diseases:Investigated Drugs:
Study Comparing Polatuzumab Vedotin with Rituximab, Ifosfamide, Carboplatin, and Etoposide for Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Not recruiting
Investigated Diseases:Investigated Drugs:
Study Comparing Loncastuximab Tesirine and Rituximab with Standard Treatment for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Not recruiting
Investigated Diseases:Investigated Drugs:
+2